β-enolase deficiency, a new metabolic myopathy of distal glycolysis

Giacomo P. Comi, Francesco Fortunato, Sabrina Lucchiari, Andreina Bordoni, Alessandro Prelle, Stefano Jann, Angeand́lica Keller, Patrizia Ciscato, Sara Galbiati, Luca Chiveri, Yvan Torrente, Guglielmo Scarlato, Nereo Bresolin

Research output: Contribution to journalArticle

Abstract

A severe muscle enolase deficiency, with 5% of residual activity, was detected in a 47-year-old man affected with exercise intolerance and myalgias. No rise of serum lactate was observed with the ischemic forearm exercise. Ultrastructural analysis showed focal sarcoplasmic accumulation of glycogen β particles. The enzyme enolase catalyzes the interconversion of 2-phosphoglycerate and phosphoenolpyruvate. In adult human muscle, over 90% of enolase activity is accounted for by the β-enolase subunit, the protein product of the ENO3 gene. The β-enolase protein was dramatically reduced in the muscle of our patient, by both immunohistochemistry and immunoblotting, while α-enolase was normally represented. The ENO3 gene of our patient carries two heterozygous missense mutations affecting highly conserved amino acid residues: a G467A transition changing a glycine residue at position 156 to aspartate, in close proximity to the catalytic site, and a G1121A transition changing a glycine to glutamate at position 374. These mutations were probably inherited as autosomal recessive traits since the mother was heterozygous for the G467A and a sister was heterozygous for the G1121A transition. Our data suggest that ENO3 mutations result in decreased stability of mutant β-enolase. Muscle β-enolase deficiency should be considered in the differential diagnosis of metabolic myopathies due to inherited defects of distal glycolysis.

Original languageEnglish
Pages (from-to)202-207
Number of pages6
JournalAnnals of Neurology
Volume50
Issue number2
DOIs
Publication statusPublished - 2001

Fingerprint

Distal Myopathies
Phosphopyruvate Hydratase
Glycolysis
Muscles
Glycine
Exercise
Mutation
Phosphoenolpyruvate
Myalgia
Muscular Diseases
Missense Mutation
Glycogen
Immunoblotting
Forearm
Aspartic Acid
Siblings
Glutamic Acid
Lactic Acid
Catalytic Domain
Proteins

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

β-enolase deficiency, a new metabolic myopathy of distal glycolysis. / Comi, Giacomo P.; Fortunato, Francesco; Lucchiari, Sabrina; Bordoni, Andreina; Prelle, Alessandro; Jann, Stefano; Keller, Angeand́lica; Ciscato, Patrizia; Galbiati, Sara; Chiveri, Luca; Torrente, Yvan; Scarlato, Guglielmo; Bresolin, Nereo.

In: Annals of Neurology, Vol. 50, No. 2, 2001, p. 202-207.

Research output: Contribution to journalArticle

Comi, GP, Fortunato, F, Lucchiari, S, Bordoni, A, Prelle, A, Jann, S, Keller, A, Ciscato, P, Galbiati, S, Chiveri, L, Torrente, Y, Scarlato, G & Bresolin, N 2001, 'β-enolase deficiency, a new metabolic myopathy of distal glycolysis', Annals of Neurology, vol. 50, no. 2, pp. 202-207. https://doi.org/10.1002/ana.1095
Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S et al. β-enolase deficiency, a new metabolic myopathy of distal glycolysis. Annals of Neurology. 2001;50(2):202-207. https://doi.org/10.1002/ana.1095
Comi, Giacomo P. ; Fortunato, Francesco ; Lucchiari, Sabrina ; Bordoni, Andreina ; Prelle, Alessandro ; Jann, Stefano ; Keller, Angeand́lica ; Ciscato, Patrizia ; Galbiati, Sara ; Chiveri, Luca ; Torrente, Yvan ; Scarlato, Guglielmo ; Bresolin, Nereo. / β-enolase deficiency, a new metabolic myopathy of distal glycolysis. In: Annals of Neurology. 2001 ; Vol. 50, No. 2. pp. 202-207.
@article{5fca2a76529b4e68b84fa5b65961e2a5,
title = "β-enolase deficiency, a new metabolic myopathy of distal glycolysis",
abstract = "A severe muscle enolase deficiency, with 5{\%} of residual activity, was detected in a 47-year-old man affected with exercise intolerance and myalgias. No rise of serum lactate was observed with the ischemic forearm exercise. Ultrastructural analysis showed focal sarcoplasmic accumulation of glycogen β particles. The enzyme enolase catalyzes the interconversion of 2-phosphoglycerate and phosphoenolpyruvate. In adult human muscle, over 90{\%} of enolase activity is accounted for by the β-enolase subunit, the protein product of the ENO3 gene. The β-enolase protein was dramatically reduced in the muscle of our patient, by both immunohistochemistry and immunoblotting, while α-enolase was normally represented. The ENO3 gene of our patient carries two heterozygous missense mutations affecting highly conserved amino acid residues: a G467A transition changing a glycine residue at position 156 to aspartate, in close proximity to the catalytic site, and a G1121A transition changing a glycine to glutamate at position 374. These mutations were probably inherited as autosomal recessive traits since the mother was heterozygous for the G467A and a sister was heterozygous for the G1121A transition. Our data suggest that ENO3 mutations result in decreased stability of mutant β-enolase. Muscle β-enolase deficiency should be considered in the differential diagnosis of metabolic myopathies due to inherited defects of distal glycolysis.",
author = "Comi, {Giacomo P.} and Francesco Fortunato and Sabrina Lucchiari and Andreina Bordoni and Alessandro Prelle and Stefano Jann and Angeand́lica Keller and Patrizia Ciscato and Sara Galbiati and Luca Chiveri and Yvan Torrente and Guglielmo Scarlato and Nereo Bresolin",
year = "2001",
doi = "10.1002/ana.1095",
language = "English",
volume = "50",
pages = "202--207",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - β-enolase deficiency, a new metabolic myopathy of distal glycolysis

AU - Comi, Giacomo P.

AU - Fortunato, Francesco

AU - Lucchiari, Sabrina

AU - Bordoni, Andreina

AU - Prelle, Alessandro

AU - Jann, Stefano

AU - Keller, Angeand́lica

AU - Ciscato, Patrizia

AU - Galbiati, Sara

AU - Chiveri, Luca

AU - Torrente, Yvan

AU - Scarlato, Guglielmo

AU - Bresolin, Nereo

PY - 2001

Y1 - 2001

N2 - A severe muscle enolase deficiency, with 5% of residual activity, was detected in a 47-year-old man affected with exercise intolerance and myalgias. No rise of serum lactate was observed with the ischemic forearm exercise. Ultrastructural analysis showed focal sarcoplasmic accumulation of glycogen β particles. The enzyme enolase catalyzes the interconversion of 2-phosphoglycerate and phosphoenolpyruvate. In adult human muscle, over 90% of enolase activity is accounted for by the β-enolase subunit, the protein product of the ENO3 gene. The β-enolase protein was dramatically reduced in the muscle of our patient, by both immunohistochemistry and immunoblotting, while α-enolase was normally represented. The ENO3 gene of our patient carries two heterozygous missense mutations affecting highly conserved amino acid residues: a G467A transition changing a glycine residue at position 156 to aspartate, in close proximity to the catalytic site, and a G1121A transition changing a glycine to glutamate at position 374. These mutations were probably inherited as autosomal recessive traits since the mother was heterozygous for the G467A and a sister was heterozygous for the G1121A transition. Our data suggest that ENO3 mutations result in decreased stability of mutant β-enolase. Muscle β-enolase deficiency should be considered in the differential diagnosis of metabolic myopathies due to inherited defects of distal glycolysis.

AB - A severe muscle enolase deficiency, with 5% of residual activity, was detected in a 47-year-old man affected with exercise intolerance and myalgias. No rise of serum lactate was observed with the ischemic forearm exercise. Ultrastructural analysis showed focal sarcoplasmic accumulation of glycogen β particles. The enzyme enolase catalyzes the interconversion of 2-phosphoglycerate and phosphoenolpyruvate. In adult human muscle, over 90% of enolase activity is accounted for by the β-enolase subunit, the protein product of the ENO3 gene. The β-enolase protein was dramatically reduced in the muscle of our patient, by both immunohistochemistry and immunoblotting, while α-enolase was normally represented. The ENO3 gene of our patient carries two heterozygous missense mutations affecting highly conserved amino acid residues: a G467A transition changing a glycine residue at position 156 to aspartate, in close proximity to the catalytic site, and a G1121A transition changing a glycine to glutamate at position 374. These mutations were probably inherited as autosomal recessive traits since the mother was heterozygous for the G467A and a sister was heterozygous for the G1121A transition. Our data suggest that ENO3 mutations result in decreased stability of mutant β-enolase. Muscle β-enolase deficiency should be considered in the differential diagnosis of metabolic myopathies due to inherited defects of distal glycolysis.

UR - http://www.scopus.com/inward/record.url?scp=0034909902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034909902&partnerID=8YFLogxK

U2 - 10.1002/ana.1095

DO - 10.1002/ana.1095

M3 - Article

C2 - 11506403

AN - SCOPUS:0034909902

VL - 50

SP - 202

EP - 207

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -